TPIV-300

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameTPIV-300

Drug Alias NameMVA-TAP vaccine adjuvant (TapImmune)smallpox vaccine (TapImmune)MVA-TAPTPIV-300

ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsSmallpox

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMarker Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMarker Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsSmallpox

Other Information

ATC CodeN/A